Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Autoimmune Disorders

Free Subscription Articles published in Neurology Retrieve available abstracts of 236 articles: HTML format Text format

Single Articles

March 2010
1. KILLESTEIN J , van der Meer ML, Regelink JC, Huijgens PC, et al
   Severe cardiac failure in a patient with multiple sclerosis following low-dose mitoxantrone treatment.
   Neurology. 2010;74:934.
   PubMed     Text format     Related articles   
   
   
   
2. BEJAOUI K , Rolak LA
   What is the risk of permanent disability from a multiple sclerosis relapse?
   Neurology. 2010;74:900-2.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. FLEMING JO , Carrithers MD
   Diagnosis and management of multiple sclerosis: A handful of patience.
   Neurology. 2010;74:876-7.
   PubMed     Text format     Related articles   
   
   
   
4. SARGSYAN SA , Shearer AJ, Ritchie AM, Burgoon MP, et al
   Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis.
   Neurology. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. RIVERA VM
   The challenge of follow-on biologics for treatment of multiple sclerosis.
   Neurology. 2010;74:864.
   PubMed     Text format     Related articles   
   
   
   
6. DAVIS M , Auh S, Riva M, Richert ND, et al
   Ring and nodular multiple sclerosis lesions: A retrospective natural history study.
   Neurology. 2010;74:851-6.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. MATSUI N , Nakane S, Saito F, Ohigashi I, et al
   Undiminished regulatory T cells in the thymus of patients with myasthenia gravis.
   Neurology. 2010;74:816-20.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. FOX RJ
   Primary neuroprotection. The Holy Grail of multiple sclerosis therapy.
   Neurology. 2010.
   PubMed     Text format     Related articles   
   
   
   
9. BARKHOF F , Hulst HE, Drulovic J, Uitdehaag BM, et al
   Ibudilast in relapsing-remitting multiple sclerosis. A neuroprotectant?
   Neurology. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. ZELLER D , Aufm Kampe K, Biller A, Stefan K, et al
    Rapid-onset central motor plasticity in multiple sclerosis.
    Neurology. 2010;74:728-35.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2010
11. HOFER S , Linnebank M, Weller M, Bahmanyar S, et al
    Cancer risk among patients with multiple sclerosis and their parents.
    Neurology. 2010;74:614-5.
    PubMed     Text format     Related articles   
    
    
    
12. ISLAM Z , Jacobs BC, van Belkum A, Mohammad QD, et al
    Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh.
    Neurology. 2010;74:581-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. PENNY S , Khaleeli Z, Cipolotti L, Thompson A, et al
    Early imaging predicts later cognitive impairment in primary progressive multiple sclerosis.
    Neurology. 2010;74:545-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. BENARROCH EE
    Adenosine triphosphate: a multifaceted chemical signal in the nervous system.
    Neurology. 2010;74:601-7.
    PubMed     Text format     Related articles   
    
    
    
15. GUTWINSKI S , Erbe S, Munch C, Janke O, et al
    Severe cutaneous Candida infection during natalizumab therapy in multiple sclerosis.
    Neurology. 2010;74:521-3.
    PubMed     Text format     Related articles   
    
    
    
16. SMIDA-RYNKOWSKA K , Belabed MR, Rynkowski M, Vokaer M, et al
    Neuropsychiatric disorders revealing primary antiphospholipid syndrome in an elderly patient.
    Neurology. 2010;74:439-40.
    PubMed     Text format     Related articles   
    
    
    
17. CHABAS D , Ness J, Belman A, Yeh EA, et al
    Younger children with MS have a distinct CSF inflammatory profile at disease onset.
    Neurology. 2010;74:399-405.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2010
18. CALABRESE M , Rinaldi F, Mattisi I, Grossi P, et al
    Widespread cortical thinning characterizes patients with MS with mild cognitive impairment.
    Neurology. 2010;74:321-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. WEINSTOCK-GUTTMAN B , Ramanathan M, Hashmi K, Abdelrahman N, et al
    Increased tissue damage and lesion volumes in African Americans with multiple sclerosis.
    Neurology. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. CREE B , Waubant E
    Does race matter for multiple sclerosis?
    Neurology. 2010.
    PubMed     Text format     Related articles   
    
    
    
21. MARRIE RA , Yu N, Blanchard J, Leung S, et al
    The rising prevalence and changing age distribution of multiple sclerosis in Manitoba.
    Neurology. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. ROCCA MA , Ceccarelli A, Rodegher M, Misci P, et al
    Preserved brain adaptive properties in patients with benign multiple sclerosis.
    Neurology. 2010;74:142-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. OKADA K , Matsushita T, Kira J, Tsuji S, et al
    B-cell activating factor of the TNF family is upregulated in neuromyelitis optica.
    Neurology. 2010;74:177-8.
    PubMed     Text format     Related articles   
    
    
    
24. MONTALBAN X , Tintore M, Swanton J, Barkhof F, et al
    MRI criteria for MS in patients with clinically isolated syndromes.
    Neurology. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. PAPPAS DJ , Oksenberg JR
    Multiple sclerosis pharmacogenomics: maximizing efficacy of therapy.
    Neurology. 2010;74 Suppl 1:S62-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. LEIST TP , Marks S
    Magnetic resonance imaging and treatment effects of multiple sclerosis therapeutics.
    Neurology. 2010;74 Suppl 1:S54-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. RAMMOHAN KW , Shoemaker J
    Emerging multiple sclerosis oral therapies.
    Neurology. 2010;74 Suppl 1:S47-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. RACKE MK , Lovett-Racke AE, Karandikar NJ
    The mechanism of action of glatiramer acetate treatment in multiple sclerosis.
    Neurology. 2010;74 Suppl 1:S25-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. KASPER LH , Shoemaker J
    Multiple sclerosis immunology: The healthy immune system vs the MS immune system.
    Neurology. 2010;74 Suppl 1:S2-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. DHIB-JALBUT S , Marks S
    Interferon-beta mechanisms of action in multiple sclerosis.
    Neurology. 2010;74 Suppl 1:S17-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. LISAK RP , Korngold S
    Insights for practice: where mechanism of action meets patient management.
    Neurology. 2010;74 Suppl 1:S70-3.
    PubMed     Text format     Related articles   
    
    
    
32. VOLLMER T , Stewart T, Baxter N
    Mitoxantrone and cytotoxic drugs' mechanisms of action.
    Neurology. 2010;74 Suppl 1:S41-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. BIELEKOVA B , Becker BL
    Monoclonal antibodies in MS: mechanisms of action.
    Neurology. 2010;74 Suppl 1:S31-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2009
34. RAMAGOPALAN SV , Link J, Byrnes JK, Dyment DA, et al
    HLA-DRB1 and month of birth in multiple sclerosis.
    Neurology. 2009;73:2107-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. MCKEON A , Pittock SJ, Lennon VA
    Stiff-person syndrome with amphiphysin antibodies: distinctive features of a rare disease.
    Neurology. 2009;73:2132.
    PubMed     Text format     Related articles   
    
    
    
36. KOCH M , Kingwell E, Rieckmann P, Tremlett H, et al
    The natural history of primary progressive multiple sclerosis.
    Neurology. 2009;73:1996-2002.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. SELLEBJERG F , Bornsen L, Khademi M, Krakauer M, et al
    Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS.
    Neurology. 2009;73:2003-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. TENSER RB , Ebers GC, Daumer M
    MRI asanoutcomein multiple sclerosis clinical trials.
    Neurology. 2009;73:1933-4.
    PubMed     Text format     Related articles   
    
    
    
39. SORMANI MP , Filippi M, De Stefano N, Ebers G, et al
    MRI ASANOUTCOMEIN MULTIPLE SCLEROSIS CLINICAL TRIALS.
    Neurology. 2009;73:1932-1933.
    PubMed     Text format     Related articles   
    
    
    
40. THURTELL MJ , Bala E, Yaniglos SS, Rucker JC, et al
    Evaluation of optic neuropathy in multiple sclerosis using low-contrast visual evoked potentials.
    Neurology. 2009;73:1849-57.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. TEUNISSEN CE , Petzold A, Bennett JL, Berven FS, et al
    A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.
    Neurology. 2009;73:1914-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. MARTINELLI V , Rocca MA, Annovazzi P, Pulizzi A, et al
    A short-term randomized MRI study of high-dose oral vs intravenous methylprednisolone in MS.
    Neurology. 2009;73:1842-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. JAFARI N , Kreft KL, Flach HZ, Janssens AC, et al
    Callosal lesion predicts future attacks after clinically isolated syndrome.
    Neurology. 2009;73:1837-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
44. DAROFF RB , Dell'osso LF, Frohman Faan EM, Beeravolu LR, et al
    "NOT MULTIPLE SCLEROSIS" AND THE CHANGING FACE OF HTLV-1: A CASE REPORT OF DOWNBEAT NYSTAGMUS.
    Neurology. 2009;73:1812-1813.
    PubMed     Text format     Related articles   
    
    
    
45. REIMANN J , Jacobson L, Vincent A, Kornblum C, et al
    Endplate destruction due to maternal antibodies in arthrogryposis multiplex congenita.
    Neurology. 2009;73:1806-8.
    PubMed     Text format     Related articles   
    
    
    
46. KELLY VM , Nelson LM, Chakravarty EF
    Obstetric outcomes in women with multiple sclerosis and epilepsy.
    Neurology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. FRANKLIN GM , Tremlett H
    Multiple sclerosis and pregnancy. What should we be telling our patients?
    Neurology. 2009.
    PubMed     Text format     Related articles   
    
    
    
48. MOORE F , Okuda DT
    Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome.
    Neurology. 2009;73:1714.
    PubMed     Text format     Related articles   
    
    
    
49. BELLMANN-STROBL J , Wuerfel J, Aktas O, Dorr J, et al
    Poor PASAT performance correlates with MRI contrast enhancement in multiple sclerosis.
    Neurology. 2009;73:1624-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. MCMASTER J , Gibson G, Castro-Prado F, Vitali A, et al
    Neurosurgical treatment of tremor in anti-myelin-associated glycoprotein neuropathy.
    Neurology. 2009;73:1707-8.
    PubMed     Text format     Related articles   
    
    
    
51. YANAGAWA K , Kawachi I, Toyoshima Y, Yokoseki A, et al
    Pathologic and immunologic profiles of a limited form of neuromyelitis optica with myelitis.
    Neurology. 2009;73:1628-37.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. KUMAR R S , Kuruvilla A
    Teaching NeuroImages: Acute hemorrhagic leukoencephalitis after mumps.
    Neurology. 2009;73:e98.
    PubMed     Text format     Related articles   
    
    
    
53. ITO S
    Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders.
    Neurology. 2009;73:1604.
    PubMed     Text format     Related articles   
    
    
    
54. MUNGER KL , Chitnis T, Ascherio A
    Body size and risk of MS in two cohorts of US women.
    Neurology. 2009;73:1543-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. MARRIE RA , Cutter G
    Relapses in multiple sclerosis. Important or not?
    Neurology. 2009.
    PubMed     Text format     Related articles   
    
    
    
56. TREMLETT H , Yousefi M, Devonshire V, Rieckmann P, et al
    Impact of multiple sclerosis relapses on progression diminishes with time.
    Neurology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. KIMPINSKI K , Iodice V, Sandroni P, Fealey RD, et al
    Sudomotor dysfunction in autoimmune autonomic ganglionopathy.
    Neurology. 2009;73:1501-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. PACHNER AR , Cadavid D, Wolansky L, Skurnick J, et al
    Effect of anti-IFN{beta} antibodies on MRI lesions of MS patients in the BECOME study.
    Neurology. 2009;73:1485-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. DALGAS U , Stenager E, Jakobsen J, Petersen T, et al
    Resistance training improves muscle strength and functional capacity in multiple sclerosis.
    Neurology. 2009;73:1478-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. PACHNER AR , Warth JD, Pace A, Goelz S, et al
    Effect of neutralizing antibodies on biomarker responses to interferon beta: the INSIGHT study.
    Neurology. 2009;73:1493-500.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
61. MARRIE RA , Cutter G, Tyry T, Vollmer T, et al
    A cross-sectional study of bone health in multiple sclerosis.
    Neurology. 2009;73:1394-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. LIEVRE M , Costagliola D, Evans S, Fourrier A, et al
    Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood.
    Neurology. 2009;73:1426-7.
    PubMed     Text format     Related articles   
    
    
    
63. PUCCIONI-SOHLER M , Soares CN, Papaiz-Alvarenga R, Castro MJ, et al
    Neurologic dengue manifestations associated with intrathecal specific immune response.
    Neurology. 2009;73:1413-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. SOLE G , Perez F, Ferrer X
    Teaching NeuroImages: reversible ectropion in myasthenia gravis.
    Neurology. 2009;73:e83.
    PubMed     Text format     Related articles   
    
    
    
65. CORTESE A , Tavazzi E, Delbue S, Alfonsi E, et al
    Varicella zoster virus-associated polyradiculoneuritis.
    Neurology. 2009;73:1334-5.
    PubMed     Text format     Related articles   
    
    
    
66. GILBERT DL , Kurlan R
    PANDAS: horse or zebra?
    Neurology. 2009;73:1252-3.
    PubMed     Text format     Related articles   
    
    
    
67. GRINSPAN ZM , Willey JZ, Tullman MJ, Elkind MS, et al
    Clinical Reasoning: a 28-year-old pregnant woman with encephalopathy.
    Neurology. 2009;73:e74-9.
    PubMed     Text format     Related articles   
    
    
    
68. ZORRO O , Lobato-Polo J, Kano H, Flickinger JC, et al
    Gamma knife radiosurgery for multiple sclerosis-related trigeminal neuralgia.
    Neurology. 2009;73:1149-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
69. SALVATORE E , Morra VB, Orefice G
    Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis.
    Neurology. 2009;73:1078.
    PubMed     Text format     Related articles   
    
    
    
70. ENGEL WK
    Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.
    Neurology. 2009;73:1077.
    PubMed     Text format     Related articles   
    
    
    
71. VAN DER WALT A , Stankovich J, Bahlo M, Taylor BV, et al
    Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy.
    Neurology. 2009;73:1018-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. RUGBJERG K , Friis S, Ritz B, Schernhammer ES, et al
    Autoimmune disease and risk for Parkinson disease. A population-based case-control study.
    Neurology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. DORR J , Bitsch A, Schmailzl KJ, Chan A, et al
    Severe cardiac failure in a patient with multiple sclerosis following low-dose mitoxantrone treatment.
    Neurology. 2009;73:991-3.
    PubMed     Text format     Related articles   
    
    
    
74. KLAWITER EC , Cross AH, Naismith RT
    The present efficacy of multiple sclerosis therapeutics: Is the new 66% just the old 33%?
    Neurology. 2009;73:984-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. LLUFRIU S , Castillo J, Blanco Y, Ramio-Torrenta L, et al
    Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months.
    Neurology. 2009;73:949-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. MENGE T , Schloot NC, Schott M, Hemmer B, et al
    Interferon beta treatment does not induce organ-specific autoantibodies in multiple sclerosis.
    Neurology. 2009;73:900-2.
    PubMed     Text format     Related articles   
    
    
    
77. SCHULTE C , Synofzik M, Gasser T, Schols L, et al
    Ataxia with ophthalmoplegia or sensory neuropathy is frequently caused by POLG mutations.
    Neurology. 2009;73:898-900.
    PubMed     Text format     Related articles   
    
    
    
78. MATTA M , Leigh RJ, Pugliatti M, Aiello I, et al
    Using fast eye movements to study fatigue in multiple sclerosis.
    Neurology. 2009;73:798-804.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. HEDSTROM AK , Baarnhielm M, Olsson T, Alfredsson L, et al
    Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis.
    Neurology. 2009;73:696-701.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. KUIJF ML , Eurelings M, Tio-Gillen AP, van Doorn PA, et al
    Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy.
    Neurology. 2009;73:688-95.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
81. PIRKO I , Zivadinov R
    Transcranial sonography of deep gray nuclei. A new outcome measure in multiple sclerosis?
    Neurology. 2009.
    PubMed     Text format     Related articles   
    
    
    
82. CHARD DT , Miller DH
    What you see depends on how you look. Gray matter lesions in multiple sclerosis.
    Neurology. 2009.
    PubMed     Text format     Related articles   
    
    
    
83. REINGOLD SC , Steiner JP, Polman CH, Cohen JA, et al
    The challenge of follow-on biologics for treatment of multiple sclerosis.
    Neurology. 2009;73:552-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. ZIVADINOV R , Weinstock-Guttman B, Hashmi K, Abdelrahman N, et al
    Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis.
    Neurology. 2009;73:504-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. BENEDICT RH , Fazekas F
    Benign or not benign MS: a role for routine neuropsychological assessment?
    Neurology. 2009;73:494-5.
    PubMed     Text format     Related articles   
    
    
    
86. WALTER U , Wagner S, Horowski S, Benecke R, et al
    Transcranial brain sonography findings predict disease progression in multiple sclerosis.
    Neurology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
87. HESSE D , Sellebjerg F, Sorensen PS
    Absence of MxA induction by interferon beta in patients with MS reflects complete loss of bioactivity.
    Neurology. 2009;73:372-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
88. PORTACCIO E , Stromillo ML, Goretti B, Zipoli V, et al
    Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
    Neurology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. ROSE JW
    Multiple sclerosis. Evidence of maternal effects and an increasing incidence in women.
    Neurology. 2009.
    PubMed     Text format     Related articles   
    
    
    
90. MAINERO C , Benner T, Radding A, van der Kouwe A, et al
    In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI.
    Neurology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. RATCHFORD JN , Quigg ME, Conger A, Frohman T, et al
    Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies.
    Neurology. 2009;73:302-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. TSCHAMPA HJ , Niehusmann P, Marek M, Mueller CA, et al
    MRI in amyloid beta--related brain angiitis.
    Neurology. 2009;73:247.
    PubMed     Text format     Related articles   
    
    
    
93. HELDAL AT , Owe JF, Gilhus NE, Romi F, et al
    Seropositive myasthenia gravis: a nationwide epidemiologic study.
    Neurology. 2009;73:150-1.
    PubMed     Text format     Related articles   
    
    
    
94. FUGATE JE , Smith JH, Claassen DO
    Bilateral cochlear enhancement in Cogan syndrome.
    Neurology. 2009;73:75.
    PubMed     Text format     Related articles   
    
    
    
95. TEO JT , Swayne OB, Silber E
    Cerebellar ataxia after malaria.
    Neurology. 2009;73:73-4.
    PubMed     Text format     Related articles   
    
    
    
96. LAUGHLIN RS , Dyck PJ, Melton LJ 3rd, Leibson C, et al
    Incidence and prevalence of CIDP and the association of diabetes mellitus.
    Neurology. 2009;73:39-45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. LUNEMANN JD , Ascherio A
    Immune responses to EBNA1: biomarkers in MS?
    Neurology. 2009;73:13-4.
    PubMed     Text format     Related articles   
    
    
    June 2009
98. KHAN OA , Tselis A, Boster A
    Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.
    Neurology. 2009;72:2134.
    PubMed     Text format     Related articles   
    
    
    
99. BEERAVOLU LR , Frohman EM, Frohman TC, Remington GM, et al
    Pearls & Oy-sters: "Not multiple sclerosis" and the changing face of HTLV-1: A case report of downbeat nystagmus.
    Neurology. 2009;72:e119-20.
    PubMed     Text format     Related articles   
    
    
    
100. WILDEMANN B , Jarius S, Hartmann M, Regula JU, et al
     Acute disseminated encephalomyelitis following vaccination against human papilloma virus.
     Neurology. 2009;72:2132-3.
     PubMed     Text format     Related articles   
     
     
     
101. ECHANIZ-LAGUNA A , Philippi N
     Teaching neuroimages: Chronic inflammatory demyelinating polyradiculoneuropathy causing spinal cord compression.
     Neurology. 2009;72:e121.
     PubMed     Text format     Related articles   
     
     
     
102. YEH EA , Weinstock-Guttman B
     Moving on to second-line therapies in pediatric MS: Immunosuppression with cyclophosphamide.
     Neurology. 2009;72:2064-5.
     PubMed     Text format     Related articles   
     
     
     
103. RAMAGOPALAN SV , Yee IM, Dyment DA, Orton SM, et al
     Parent-of-origin effect in multiple sclerosis. Observations from interracial matings.
     Neurology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
104. IODICE V , Kimpinski K, Vernino S, Sandroni P, et al
     Efficacy of immunotherapy in seropositive and seronegative putative autoimmune autonomic ganglionopathy.
     Neurology. 2009;72:2002-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
105. D'NETTO MJ , Ward H, Morrison KM, Ramagopalan SV, et al
     Risk alleles for multiple sclerosis in multiplex families.
     Neurology. 2009;72:1984-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
106. FOLEY JF , Brandes DW
     Redefining functionality and treatment efficacy in multiple sclerosis.
     Neurology. 2009;72.
     PubMed     Text format     Related articles    Abstract available
     
     
     
107. BRAILLON A , Dubois G
     Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood.
     Neurology. 2009;72:2053.
     PubMed     Text format     Related articles   
     
     
     
108. VERSINO M , Franciotta D, Colnaghi S, Biagi F, et al
     Cerebellar signs in celiac disease.
     Neurology. 2009;72:2046-8.
     PubMed     Text format     Related articles   
     
     
     
109. RUDICK RA , Pace A, Rani MR, Hyde R, et al
     Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a.
     Neurology. 2009;72:1989-93.
     PubMed     Text format     Related articles    Abstract available
     
     
     
110. FOX RJ , Arnold DL
     Seeing injectable MS therapies differently: they are more similar than different.
     Neurology. 2009;72:1972-3.
     PubMed     Text format     Related articles   
     
     
     
111. MARKOVIC-PLESE S , Jewells V, Speer D
     Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis.
     Neurology. 2009;72:1965.
     PubMed     Text format     Related articles   
     
     
     
112. NISHIYAMA S , Ito T, Misu T, Takahashi T, et al
     A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset.
     Neurology. 2009;72:1960-1.
     PubMed     Text format     Related articles   
     
     
     
113. KIVISAKK P , Healy BC, Viglietta V, Quintana FJ, et al
     Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells.
     Neurology. 2009;72:1922-30.
     PubMed     Text format     Related articles    Abstract available
     
     
     
114. GOLDSCHMIDT T , Antel J, Konig FB, Bruck W, et al
     Remyelination capacity of the MS brain decreases with disease chronicity.
     Neurology. 2009;72:1914-21.
     PubMed     Text format     Related articles    Abstract available
     
     
     May 2009
115. PITTOCK SJ , Lennon VA, McKeon A
     Stiff eyes in stiff-person syndrome.
     Neurology. 2009;72:1877-8.
     PubMed     Text format     Related articles   
     
     
     
116. PUTAALA J , Kurkinen M, Tarvos V, Salonen O, et al
     Silent brain infarcts and leukoaraiosis in young adults with first-ever ischemic stroke.
     Neurology. 2009;72:1823-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
117. FARRELL RA , Antony D, Wall GR, Clark DA, et al
     Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
     Neurology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
118. MOWRY EM , Beheshtian A, Waubant E, Goodin DS, et al
     Quality of life in multiple sclerosis is associated with lesion burden and brain volume measures.
     Neurology. 2009;72:1760-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
119. STEINER I
     Quantitative risk-benefit analysis of natalizumab.
     Neurology. 2009;72:1791-2.
     PubMed     Text format     Related articles   
     
     
     
120. MAKHANI N , Gorman MP, Branson HM, Stazzone L, et al
     Cyclophosphamide therapy in pediatric multiple sclerosis.
     Neurology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
121. SELMAJ K , Jurewicz A, Matysiak M, Raine CS, et al
     Soluble Nogo-A in CSF is not a useful biomarker for multiple sclerosis.
     Neurology. 2009;72:1708.
     PubMed     Text format     Related articles   
     
     
     
122. ROVARIS M , Barkhof F, Calabrese M, De Stefano N, et al
     MRI features of benign multiple sclerosis: toward a new definition of this disease phenotype.
     Neurology. 2009;72:1693-701.
     PubMed     Text format     Related articles    Abstract available
     
     
     
123. GREEN AJ
     Understanding pseudo: the symptoms are real, the cause is unclear.
     Neurology. 2009;72:1626-7.
     PubMed     Text format     Related articles   
     
     
     
124. VILLOSLADA P , Arrondo G, Sepulcre J, Alegre M, et al
     Memantine induces reversible neurologic impairment in patients with MS.
     Neurology. 2009;72:1630-3.
     PubMed     Text format     Related articles    Abstract available
     
     
     
125. ALSHEKHLEE A , Miles JD, Katirji B, Preston DC, et al
     Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals.
     Neurology. 2009;72:1548-54.
     PubMed     Text format     Related articles    Abstract available
     
     
     
126. COHEN M , Rocher F, Brunschwig C, Lebrun C, et al
     Recurrent pericarditis due to natalizumab treatment.
     Neurology. 2009;72:1616-7.
     PubMed     Text format     Related articles   
     
     
     April 2009
127. DEBIAIS S , Bonnaud I, Ferreira-Maldent N, Mercier E, et al
     Neuropsychiatric disorders revealing primary antiphospholipid syndrome in an elderly patient.
     Neurology. 2009;72:1362-3.
     PubMed     Text format     Related articles   
     
     
     
128. CALABRESE M , Rocca MA, Atzori M, Mattisi I, et al
     Cortical lesions in primary progressive multiple sclerosis: a 2-year longitudinal MR study.
     Neurology. 2009;72:1330-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
129. TEUNISSEN CE , Iacobaeus E, Khademi M, Brundin L, et al
     Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.
     Neurology. 2009;72:1322-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
130. MERKIES IS , Bril V, Dalakas MC, Deng C, et al
     Health-related quality-of-life improvements in CIDP with immune globulin IV 10%: the ICE Study.
     Neurology. 2009;72:1337-44.
     PubMed     Text format     Related articles    Abstract available
     
     
     
131. PITTMAN GL
     Re: Economic cost of Guillain-Barre syndrome in the United States.
     Neurology. 2009;72:1282.
     PubMed     Text format     Related articles   
     
     
     
132. RODRIGUEZ M , Warrington AE, Pease LR
     Invited Article: Human natural autoantibodies in the treatment of neurologic disease.
     Neurology. 2009;72:1269-76.
     PubMed     Text format     Related articles    Abstract available
     
     
     
133. SINGER W , Engelstad JK, Dyck PJ
     NeuroImages: the beautiful feet of neuropathy.
     Neurology. 2009;72:1281.
     PubMed     Text format     Related articles   
     
     
     March 2009
134. TENSER RB , Polman CH
     Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment.
     Neurology. 2009;72:1191-2.
     PubMed     Text format     Related articles   
     
     
     
135. BAHMANYAR S , Montgomery SM, Hillert J, Ekbom A, et al
     Cancer risk among patients with multiple sclerosis and their parents.
     Neurology. 2009;72:1170-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
136. HUSSAIN H , Usman A, Raza Q, Amato MP, et al
     Cognitive and psychosocial features of childhood and juvenile MS.
     Neurology. 2009;72:1189.
     PubMed     Text format     Related articles   
     
     
     
137. BADRUDDIN A , Menon RS, Reder AT
     4-Aminopyridine toxicity mimics autoimmune-mediated limbic encephalitis.
     Neurology. 2009;72:1100-1.
     PubMed     Text format     Related articles   
     
     
     
138. NAISMITH RT , Tutlam NT, Xu J, Klawiter EC, et al
     Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis.
     Neurology. 2009;72:1077-82.
     PubMed     Text format     Related articles    Abstract available
     
     
     
139. KLAWITER EC , Alvarez E 3rd, Xu J, Paciorkowski AR, et al
     NMO-IgG detected in CSF in seronegative neuromyelitis optica.
     Neurology. 2009;72:1101-3.
     PubMed     Text format     Related articles   
     
     
     
140. WIENDL H , Hohlfeld R
     Multiple sclerosis therapeutics: unexpected outcomes clouding undisputed successes.
     Neurology. 2009;72:1008-15.
     PubMed     Text format     Related articles    Abstract available
     
     
     
141. ELKIND MS
     The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features.
     Neurology. 2009;72:1028-30.
     PubMed     Text format     Related articles   
     
     
     
142. NOBILE-ORAZIO E , Terenghi F, Giannotta C, Gallia F, et al
     Serum VEGF levels in POEMS syndrome and in immune-mediated neuropathies.
     Neurology. 2009;72:1024-6.
     PubMed     Text format     Related articles   
     
     
     
143. LEYPOLDT F , Munchau A, Moeller F, Bester M, et al
     Hemorrhaging focal encephalitis under fingolimod (FTY720) treatment: a case report.
     Neurology. 2009;72:1022-4.
     PubMed     Text format     Related articles   
     
     
     
144. CHITNIS T , Pirko I
     Sensitivity vs specificity: progress and pitfalls in defining MRI criteria for pediatric MS.
     Neurology. 2009;72:952-3.
     PubMed     Text format     Related articles   
     
     
     
145. CADAVID D , Wolansky LJ, Skurnick J, Lincoln J, et al
     Efficacy of treatment of MS with IFN{beta}-1b or glatiramer acetate by monthly brain MRI in the BECOME study.
     Neurology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
146. BONHOMME GR , Waldman AT, Balcer LJ, Daniels AB, et al
     Pediatric optic neuritis: brain MRI abnormalities and risk of multiple sclerosis.
     Neurology. 2009;72:881-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
147. DEL BORGO C , Zaniratti S, Minosse C, Vetica A, et al
     A case of acute polyradiculoneuropathy, drug-induced hypersensitivity, and HHV-6 infection.
     Neurology. 2009;72:935-6.
     PubMed     Text format     Related articles   
     
     
     
148. MIKAELOFF Y , Caridade G, Suissa S, Tardieu M, et al
     Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood.
     Neurology. 2009;72:873-80.
     PubMed     Text format     Related articles    Abstract available
     
     
     
149. SAVOLAINEN H
     Cortical demyelination in PML and MS: similarities and differences.
     Neurology. 2009;72:861.
     PubMed     Text format     Related articles   
     
     
     
150. GOODMAN AD , Rossman H, Bar-Or A, Miller A, et al
     GLANCE: results of a phase 2, randomized, double-blind, placebo-controlled study.
     Neurology. 2009;72:806-12.
     PubMed     Text format     Related articles    Abstract available
     
     
     February 2009
151. MAGANA SM , Matiello M, Pittock SJ, McKeon A, et al
     Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders.
     Neurology. 2009;72:712-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
152. KOCH-HENRIKSEN N
     No shortcuts to outcome in MS clinical trials?
     Neurology. 2009;72:686-7.
     PubMed     Text format     Related articles   
     
     
     
153. KARCESKI S
     Neuromyelitis optica.
     Neurology. 2009;72:e40-1.
     PubMed     Text format     Related articles   
     
     
     
154. MOWRY EM , Pesic M, Grimes B, Deen S, et al
     Demyelinating events in early multiple sclerosis have inherent severity and recovery.
     Neurology. 2009;72:602-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
155. RUDICK RA , Fisher E
     Brain atrophy as an outcome measure for multiple sclerosis clinical trials: a "no-brainer"?
     Neurology. 2009;72:586-7.
     PubMed     Text format     Related articles   
     
     
     
156. RAMAGOPALAN SV , Ebers GC
     Epistasis: Multiple sclerosis and the major histocompatibility complex.
     Neurology. 2009;72:566-7.
     PubMed     Text format     Related articles   
     
     
     
157. COHEN JA , Imrey PB, Calabresi PA, Edwards KR, et al
     Results of the Avonex Combination Trial (ACT) in relapsing-remitting MS.
     Neurology. 2009;72:535-41.
     PubMed     Text format     Related articles    Abstract available
     
     
     
158. SCHMIERER K , Parkes HG, So PW
     Direct visualization of remyelination in multiple sclerosis using T2-weighted high-field MRI.
     Neurology. 2009;72:472.
     PubMed     Text format     Related articles   
     
     
     
159. KHATRI BO , Man S, Giovannoni G, Koo AP, et al
     Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function.
     Neurology. 2009;72:402-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
160. SCHIESS N , Calabresi PA
     Natalizumab: bound to rebound?
     Neurology. 2009;72:392-3.
     PubMed     Text format     Related articles   
     
     
     January 2009
161. PYLE W , Dastur K, Rahman M, Tsay J, et al
     Open-ring peripherally enhancing lesion of the cervical spine.
     Neurology. 2009;72:381.
     PubMed     Text format     Related articles   
     
     
     
162. BANWELL B , Kennedy J, Sadovnick D, Arnold DL, et al
     Incidence of acquired demyelination of the CNS in Canadian children.
     Neurology. 2009;72:232-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
163. GORMAN G , Hutchinson M, Tubridy N
     Clinical reasoning: a case of Wegener granulomatosis complicated by seizures and headaches: curiouser and curiouser.
     Neurology. 2009;72:e11-4.
     PubMed     Text format     Related articles   
     
     
     
164. BARTOCCIONI E , Scuderi F, Augugliaro A, Chiatamone Ranieri S, et al
     HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5.
     Neurology. 2009;72:195-7.
     PubMed     Text format     Related articles   
     
     
     
165. WEISS N , Hasboun D, Demeret S, Fontaine B, et al
     Paroxysmal hypothermia as a clinical feature of multiple sclerosis.
     Neurology. 2009;72:193-5.
     PubMed     Text format     Related articles   
     
     
     
166. BECK CA
     Selection bias in observational studies: out of control?
     Neurology. 2009;72:108-9.
     PubMed     Text format     Related articles   
     
     
     
167. MARRIE RA , Horwitz R, Cutter G, Tyry T, et al
     Comorbidity delays diagnosis and increases disability at diagnosis in MS.
     Neurology. 2009;72:117-24.
     PubMed     Text format     Related articles    Abstract available
     
     
     
168. MESSINIS L , Papathanasopoulos P
     Multiple sclerosis and cannabis: a cognitive and psychiatric study.
     Neurology. 2009;72:100-1.
     PubMed     Text format     Related articles   
     
     
     
169. VINCENT A , Buckley C, Lang B, Irani S, et al
     Clinical spectrum of voltage-gated potassium channel autoimmunity.
     Neurology. 2009;72:99.
     PubMed     Text format     Related articles   
     
     
     
170. O'CONNOR P , Comi G, Montalban X, Antel J, et al
     Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension study.
     Neurology. 2009;72:73-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
171. WENDT M , Wohlrab J, Zierz S, Deschauer M, et al
     Efalizumab-induced isolated cerebral lupus-like syndrome.
     Neurology. 2009;72:96-7.
     PubMed     Text format     Related articles   
     
     
     December 2008
172. NESS JM , Bale JF Jr
     Hepatitis vaccines and pediatric multiple sclerosis. Does timing or type matter?
     Neurology. 2008.
     PubMed     Text format     Related articles   
     
     
     
173. OKUDA DT , Mowry EM, Beheshtian A, Waubant E, et al
     Incidental MRI anomalies suggestive of multiple sclerosis. The radiologically isolated syndrome.
     Neurology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
174. DAUMER M , Neuhaus A, Morrissey S, Hintzen R, et al
     MRI as an outcome in multiple sclerosis clinical trials.
     Neurology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
175. BOURDETTE D , Simon J
     The radiologically isolated syndrome. Is it very early multiple sclerosis?
     Neurology. 2008.
     PubMed     Text format     Related articles   
     
     
     
176. OSKOUI M , Jacobson L, Chung WK, Haddad J, et al
     Fetal acetylcholine receptor inactivation syndrome and maternal myasthenia gravis.
     Neurology. 2008;71:2010-2.
     PubMed     Text format     Related articles   
     
     
     
177. YSRRAELIT MC , Gaitan MI, Lopez AS, Correale J, et al
     Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis.
     Neurology. 2008;71:1948-54.
     PubMed     Text format     Related articles    Abstract available
     
     
     
178. GOODIN DS
     Disease-modifying therapy in multiple sclerosis: Update and clinical implications.
     Neurology. 2008;71.
     PubMed     Text format     Related articles    Abstract available
     
     
     
179. COYLE PK
     Early treatment of multiple sclerosis to prevent neurologic damage.
     Neurology. 2008;71.
     PubMed     Text format     Related articles    Abstract available
     
     
     
180. COHEN BA
     Identification, causation, alleviation, and prevention of complications (ICAP): An approach to symptom and disability management in multiple sclerosis.
     Neurology. 2008;71.
     PubMed     Text format     Related articles    Abstract available
     
     
     
181. ROSS AP
     Strategies for optimal disease management, adherence, and outcomes in multiple sclerosis patients.
     Neurology. 2008;71.
     PubMed     Text format     Related articles   
     
     
     
182. ROSS AP
     Tolerability, adherence, and patient outcomes.
     Neurology. 2008;71.
     PubMed     Text format     Related articles    Abstract available
     
     
     
183. DOHERTY MJ
     Reflections: Neurology and the humanities. Ferris wheels, fly fishing, and the dumping.
     Neurology. 2008;71:2015-7.
     PubMed     Text format     Related articles   
     
     
     
184. MURINSON BB , Guarnaccia JB
     Stiff-person syndrome with amphiphysin antibodies: distinctive features of a rare disease.
     Neurology. 2008;71:1955-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
185. SORENSEN PS
     Can we spot the IFNbeta nonresponders?
     Neurology. 2008;71:1936-7.
     PubMed     Text format     Related articles   
     
     
     
186. EVOLI A
     Antibody-phenotype correlation in stiff-person syndrome.
     Neurology. 2008;71:1938-9.
     PubMed     Text format     Related articles   
     
     
     November 2008
187. CALLEN DJ , Shroff MM, Branson HM, Lotze T, et al
     MRI in the diagnosis of pediatric multiple sclerosis.
     Neurology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
188. CALLEN DJ , Shroff MM, Branson HM, Li DK, et al
     Role of MRI in the differentiation of ADEM from MS in children.
     Neurology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
189. BURTON JM , Bell CM, Walker SE, O'Connor PW, et al
     4-aminopyridine toxicity with unintentional overdose in four patients with multiple sclerosis.
     Neurology. 2008;71:1833-4.
     PubMed     Text format     Related articles   
     
     
     
190. KUMPFEL T , Hoffmann LA, Pellkofer H, Pollmann W, et al
     Multiple sclerosis and the TNFRSF1A R92Q mutation: Clinical characteristics of 21 cases.
     Neurology. 2008;71:1812-20.
     PubMed     Text format     Related articles    Abstract available
     
     
     
191. STUVE O , Cravens PD, Frohman EM, Phillips JT, et al
     Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy.
     Neurology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
192. VILLOSLADA P , Sepulcre J, Toledo J, Bejarano B, et al
     Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis.
     Neurology. 2008;71:1747-8.
     PubMed     Text format     Related articles   
     
     
     
193. KAIDA K , Sonoo M, Ogawa G, Kamakura K, et al
     GM1/GalNAc-GD1a complex: A target for pure motor Guillain-Barre syndrome.
     Neurology. 2008;71:1683-90.
     PubMed     Text format     Related articles    Abstract available
     
     
     
194. ALTMANN DR , Jasperse B, Barkhof F, Beckmann K, et al
     Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis.
     Neurology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     October 2008
195. GILLI F , Valentino P, Caldano M, Granieri L, et al
     Expression and regulation of IFN{alpha}/{beta} receptor in IFN{beta}-treated patients with multiple sclerosis.
     Neurology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
196. 
     About multiple sclerosis.
     Neurology. 2008;71:e56.
     PubMed     Text format     Related articles   
     
     
     
197. GOLDMAN MD , Cohen JA
     Statins to treat multiple sclerosis: friend or foe?
     Neurology. 2008;71:1386-7.
     PubMed     Text format     Related articles   
     
     
     
198. LOCK C
     Are "statins" beneficial or harmful in multiple sclerosis?
     Neurology. 2008;71:e54-5.
     PubMed     Text format     Related articles   
     
     
     
199. RAMAGOPALAN SV , Dyment DA, Sadovnick AD, Ebers GC, et al
     Re: HLA-DRB1 and multiple sclerosis in Malta.
     Neurology. 2008;71:1379.
     PubMed     Text format     Related articles   
     
     
     
200. KRUMBHOLZ M , Meinl I, Kumpfel T, Hohlfeld R, et al
     Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis.
     Neurology. 2008;71:1350-4.
     PubMed     Text format     Related articles    Abstract available
     
     
     
201. BHANUSHALI MJ , Wuu J, Benatar M
     Treatment of ocular symptoms in myasthenia gravis.
     Neurology. 2008;71:1335-41.
     PubMed     Text format     Related articles    Abstract available
     
     
     
202. BURTON JM , Bell CM, Walker SE, O'Connor PW, et al
     4-Aminopyridine toxicity with unintentional overdose in four patients with multiple sclerosis.
     Neurology. 2008.
     PubMed     Text format     Related articles   
     
     
     
203. MEHLING M , Brinkmann V, Antel J, Bar-Or A, et al
     FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis.
     Neurology. 2008;71:1261-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
204. MAZUREK AA , Shi J
     APOE epsilon4 allele is associated with cognitive impairment in patients with multiple sclerosis.
     Neurology. 2008;71:1203.
     PubMed     Text format     Related articles   
     
     
     
205. MISRA UK , Kalita J
     Patterns of Guillain-Barre syndrome in children: results from a Mexican population.
     Neurology. 2008;71:1203-4.
     PubMed     Text format     Related articles   
     
     
     
206. BAR-OR A , Antel J
     Cross-reactivity between epidemiology and immunology in multiple sclerosis.
     Neurology. 2008;71:1132-3.
     PubMed     Text format     Related articles   
     
     
     
207. KRYSCIO RJ
     Fampridine for MS responders: clinically relevant or hypothesis generating?
     Neurology. 2008;71:1130-1.
     PubMed     Text format     Related articles   
     
     
     September 2008
208. CHABAS D , Castillo-Trivino T, Mowry EM, Strober JB, et al
     Vanishing MS T2-bright lesions before puberty: a distinct MRI phenotype?
     Neurology. 2008;71:1090-3.
     PubMed     Text format     Related articles    Abstract available
     
     
     
209. HSIEH DT , Singh R, Zecavati N, Emmanuel B, et al
     Teaching Video NeuroImage: near complete ophthalmoplegia in GQ1b antibody-positive Miller Fisher: video and MRI correlation.
     Neurology. 2008;71:e31.
     PubMed     Text format     Related articles   
     
     
     
210. ROVARIS M , Riccitelli G, Judica E, Possa F, et al
     Cognitive impairment and structural brain damage in benign multiple sclerosis.
     Neurology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
211. LUNEMANN JD , Huppke P, Roberts S, Bruck W, et al
     Broadened and elevated humoral immune response to EBNA1 in pediatric multiple sclerosis.
     Neurology. 2008;71:1033-5.
     PubMed     Text format     Related articles   
     
     
     
212. BANWELL BL
     Into the looking glass: predicting MS in children experiencing a first demyelinating event.
     Neurology. 2008;71:962-3.
     PubMed     Text format     Related articles   
     
     
     
213. NEUTEBOOM RF , Boon M, Catsman Berrevoets CE, Vles JS, et al
     Prognostic factors after a first attack of inflammatory CNS demyelination in children.
     Neurology. 2008;71:967-73.
     PubMed     Text format     Related articles    Abstract available
     
     
     
214. VIGLIETTA V , Bourcier K, Buckle GJ, Healy B, et al
     CTLA4Ig treatment in patients with multiple sclerosis: an open-label, phase 1 clinical trial.
     Neurology. 2008;71:917-24.
     PubMed     Text format     Related articles    Abstract available
     
     
     
215. KANTARCI OH , Spurkland A
     Parent of origin in multiple sclerosis: understanding inheritance in complex neurologic diseases.
     Neurology. 2008;71:786-7.
     PubMed     Text format     Related articles   
     
     
     
216. HERRERA BM , Ramagopalan SV, Lincoln MR, Orton SM, et al
     Parent-of-origin effects in MS: observations from avuncular pairs.
     Neurology. 2008;71:799-803.
     PubMed     Text format     Related articles    Abstract available
     
     
     
217. GOODIN DS , Cohen BA, O'Connor P, Kappos L, et al
     Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
     Neurology. 2008;71:766-73.
     PubMed     Text format     Related articles    Abstract available
     
     
     August 2008
218. WANG H , Munger KL, Reindl M, O'Reilly EJ, et al
     Myelin oligodendrocyte glycoprotein antibodies and multiple sclerosis in healthy young adults.
     Neurology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
219. AMATO MP , Portaccio E, Stromillo ML, Goretti B, et al
     Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
     Neurology. 2008;71:632-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
220. MARRIE RA
     You get what you measure: evaluating endpoints in MS clinical trials.
     Neurology. 2008;71:620-1.
     PubMed     Text format     Related articles   
     
     
     
221. EBERS GC , Heigenhauser L, Daumer M, Lederer C, et al
     Disability as an outcome in MS clinical trials.
     Neurology. 2008;71:624-31.
     PubMed     Text format     Related articles    Abstract available
     
     
     
222. DWYER T , van der Mei I, Ponsonby AL, Taylor BV, et al
     Melanocortin 1 receptor genotype, past environmental sun exposure, and risk of multiple sclerosis.
     Neurology. 2008;71:583-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
223. BRENNER SR , Brown MG, Kirby S, Skedgel C, et al
     How effective are disease-modifying drugs in delaying progression in relapsing-onset ms?
     Neurology. 2008;71:615.
     PubMed     Text format     Related articles   
     
     
     
224. ZWERGAL A , Cnyrim C, Arbusow V, Glaser M, et al
     Unilateral INO is associated with ocular tilt reaction in pontomesencephalic lesions: INO plus.
     Neurology. 2008;71:590-3.
     PubMed     Text format     Related articles    Abstract available
     
     
     
225. NOLANO M , Provitera V, Santoro L, Terme T, et al
     In vivo confocal microscopy of meissner corpuscles as a measure of sensory neuropathy.
     Neurology. 2008;71:536-7.
     PubMed     Text format     Related articles   
     
     
     
226. WILKINS DE
     Is it time to use observational data to estimate treatment effectiveness in multiple sclerosis?
     Neurology. 2008;71:463.
     PubMed     Text format     Related articles   
     
     
     
227. MILLS DA , Frohman TC, Davis SL, Salter AR, et al
     Break in binocular fusion during head turning in ms patients with ino.
     Neurology. 2008;71:458-60.
     PubMed     Text format     Related articles   
     
     
     
228. BOSCA I , Pascual AM, Casanova B, Coret F, et al
     Four new cases of therapy-related acute promyelocytic leukemia after mitoxantrone.
     Neurology. 2008;71:457-8.
     PubMed     Text format     Related articles   
     
     
     
229. BENATAR M , Rowland LP
     The muddle of mycophenolate mofetil in myasthenia.
     Neurology. 2008;71:390-1.
     PubMed     Text format     Related articles   
     
     
     July 2008
230. GOODMAN AD , Brown TR, Cohen JA, Krupp LB, et al
     Dose comparison trial of sustained-release fampridine in multiple sclerosis.
     Neurology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
231. OSKARSSON B , Pelak V, Quan D, Hall D, et al
     Stiff eyes in stiff-person syndrome.
     Neurology. 2008;71:378-80.
     PubMed     Text format     Related articles   
     
     
     
232. THOMPSON JP , Noyes K, Dorsey ER, Schwid SR, et al
     Quantitative risk-benefit analysis of natalizumab.
     Neurology. 2008;71:357-64.
     PubMed     Text format     Related articles    Abstract available
     
     
     
233. FAZEKAS F , Lublin FD, Li D, Freedman MS, et al
     Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.
     Neurology. 2008;71:265-71.
     PubMed     Text format     Related articles    Abstract available
     
     
     
234. FU DC , Montgomery JR
     High-dose, rapid-infusion IVIG in postvaccination acute disseminated encephalomyelitis.
     Neurology. 2008;71:294-5.
     PubMed     Text format     Related articles   
     
     
     
235. ARNETT PA
     Cannabis bliss? Perhaps not?
     Neurology. 2008;71:160-1.
     PubMed     Text format     Related articles   
     
     
     
236. LEE SI , Park JH, Kim JH
     Paradoxical progression of intracranial tuberculomas and anterior cerebral artery infarction.
     Neurology. 2008;71:68.
     PubMed     Text format     Related articles   
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: